The Patent Finder
US

Novel Peptides and Combination of Peptides for Use in Immunotherapy Against Prostate Cancer and Other Cancers

US 9,908,920 Lapsed on the fee record
OverviewFamilyAssignmentsSources & methods

Lapsed Mar 6, 2026 on the fee record · High confidence

Second maintenance fee unpaid; grace period ended.

Filed Aug 5, 2016 as application 15/229,970 · Granted Mar 6, 2018
Base term, 20 years from filing
Today
Lapsed Mar 6, 2026
2016 2036
Clock starts
Aug 5, 2016
No longer in force
Mar 6, 2026
Granted
Mar 6, 2018
Term would have run to
Aug 5, 2036
base term after the term ends fee events Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
24
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

Its term would have run to Aug 5, 2036: its 20-year base term, with no adjustment for prosecution delay. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Aug 5, 2016, when this application, 15/229,970, was filedAug 5, 2036High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 3 maintenance fees paidlapsed Mar 6, 2026High confidence
Computed term endThe steps above, in orderMar 6, 2026High confidence

This family

US 9,908,920this patent
Mar 2026
Mar 2026
US 9,993,539Lapsed on the fee record
Jun 2026
Jun 2026
US 10,155,032In force
Aug 2036
Aug 2036
US 10,500,259In force
Nov 2036
Nov 2036
US 10,383,930In force
Aug 2036
Aug 2036
US 10,238,727In force
Aug 2036
Aug 2036
US 10,376,568In force
Aug 2036
Aug 2036
US 10,449,238In force
Aug 2036
Aug 2036
8 of 24 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Nov 7, 2016
Reel 40243, frame 366
Mahr, Andrea; Weinschenk, Toni; Schoor, Oliver; Fritsche, Jens; Singh, Harprete; Mueller, Phillip; Leibold, Julia; Goldfinger, ValentinaImmatics Biotechnologies GmbHAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited